Bristol-Myers Squibb Canada Co. v. Teva Canada Limited, 2017 FCA 76
Linked as:
Extract
Bristol-Myers Squibb Canada Co. v. Teva Canada Limited, 2017 FCA 76
No longer available (Autolink)
See the full content of this document
This document cites
- Agraira v. Canada (Minister of Safety and Emergency Preparedness) et al., [2013] N.R. TBEd. JN.015
- Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
- Wenzel Downhole Tools Ltd. et al. v. National-Oilwell Canada Ltd. et al., (2012) 443 N.R. 173 (FCA)
- Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)
- AstraZeneca Canada Inc. et al. v. Pharmascience Inc. et al., (2014) 460 N.R. 343 (FCA)
